Spryte Medical
PrivateLast Round
Strategic
Mar 25, 2026
Est. Valuation
$80.03M
Total Funding Raised
$93.45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Spryte Medical operates in Healthcare & Life Sciences and is based in Bedford, Massachusetts. Its latest recorded funding round was a Strategic round in March 2026.
Spryte Medical is a medical device company developing an AI-enabled neuro Optical Coherence Tomography (nOCT) platform for intravascular imaging of the brain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Spryte Medical Comparables
Compare Spryte Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gentuity | 86% | |
| Vena Medical | 78% | |
| Philips | 70% |
For institutional investors. Book with your work email.
Spryte Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 25, 2026 | ||||
| M&A | Dec 19, 2025 | ||||
| Seed | Jun 5, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Spryte Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Development Bank of Japan | Strategic |
| Adams Street Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 25, 2026
Led by Development Bank of Japan
- Dec 19, 2025
$49M round led by Nipro Corp.
For institutional investors. Book with your work email.
Spryte Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Spryte Medical's valuation, stock price, and market status.
Is Spryte Medical a public or private company?
Spryte Medical is a private company.
What is the current stock price of Spryte Medical?
Spryte Medical is a private company, so its shares have no public market price. Caplight tracks Spryte Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Spryte Medical worth (valuation)?
Spryte Medical's valuation is estimated at $80.0M based on funding round data.
Can I buy Spryte Medical stock?
Spryte Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Spryte Medical's last funding round?
Spryte Medical's most recent funding round was Strategic on March 25, 2026.
Who are the main investors in Spryte Medical?
Key investors in Spryte Medical include Development Bank of Japan.
Will Spryte Medical IPO soon?
No public IPO plans have been announced for Spryte Medical.
How can I track Spryte Medical secondary market activity?
Caplight tracks bids, offers, and trades in Spryte Medical's shares on secondary markets.